The forecasted hospital discharges for hyperplasia of the prostate in Sweden from 2024 to 2028 show a progressive decline. Starting at 2.7 thousand discharges in 2024, the number is expected to decrease each year to 2.14 thousand by 2028. Based on 2023 actual data, the year-on-year variation shows a consistent decrease. For 2024, the discharges are projected to decline by 5.19% compared to 2023. The percentage decrease for 2025 is 5.19%, 2026 is 5.47%, 2027 is 5.79%, and 2028 is 6.14%. The Compound Annual Growth Rate (CAGR) over the last five years is approximately -5.56%, indicating a continual reduction in hospital discharges for this condition.
Future trends to watch for include advancements in non-surgical treatments for hyperplasia of the prostate, improvements in early detection and diagnosis, and the impact of public health initiatives focused on men's health awareness. These factors could further influence the declining trend in hospital discharges.
